QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors investigation in context of biomarkers, drug targets and pathways using Omicsoft and Ingenuity Pathway Analysis

September 15, 2022
This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with user and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.

In this training, you will learn how to:
· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases
· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, a specific disease/disease subtype and more)
· Correlate expression of multiple genes and biomarkers
· Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

1,741 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN OmicSoft trainings- 3 part series - Oct 20 (part 1)

808 views October 26, 2021

In three separate 60-minute trainings, attendees will learn how to use basic...

QIAGEN OmicSoft and Biomedical Knowledge Base

Expression data analysis using QIAGEN Omicsoft Studio - Sep 28 2021

745 views October 01, 2021

In this training, users will learn how to generate downstream outputs such...